ClinicalTrials.govpublic full text
Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease
hematological malignancies, hct, nonmyeloablative, mesenchymal stem cells, gvhd, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 811996
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.